Skip to main content
Log in

Medizinethischer Kommentar zum Fall: „Methadon zur Tumortherapie“

  • Fall und Kommentare
  • Published:
Ethik in der Medizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Hofbauer H, Schenk M, Kieselbach K, Wirz S (2017) Einsatz von Methadon zur Unterstützung der onkologischen Therapie? Eine Stellungnahme des Arbeitskreises Tumorschmerz der Deutschen Schmerzgesellschaft. Schmerz 31:2–4

    Article  CAS  PubMed  Google Scholar 

  • Miller JE, Ross JS, Moch KI, Caplan AL (2017) Characterizing expanded access and compassionate use programs for experimental drugs. BMC Res Notes. https://doi.org/10.1186/s13104017-2687-5

    Google Scholar 

  • Ojanpera I, Kriikku P, Vuori E (2016) Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med 130(5):1209–1216

    Article  PubMed  Google Scholar 

  • Ray W, Chung C, Cooper W et al (2015) Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med 175:420–427

    Article  PubMed  PubMed Central  Google Scholar 

  • Sahm S (2016) Der vorinformierte Patient. Z Med Ethik 62(4):287–298

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephan Sahm.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahm, A., Sahm, S. Medizinethischer Kommentar zum Fall: „Methadon zur Tumortherapie“. Ethik Med 29, 326–329 (2017). https://doi.org/10.1007/s00481-017-0459-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00481-017-0459-3

Navigation